Marijuana Proponents’ CBD Recommendations Smell Like COVID-19 Claims To US Regulators
Executive Summary
Living Senior claimed its CBD tinctures, oral strips and capsules could help prevent or treat COVID-19. It featured on its website recommendations by Bob Melamede, a cannabinoids, cancer, and DNA repair professor at the University of Colorado, and Richard Cowan, formerly executive director of NORML.
You may also be interested in...
Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking
Supplements containing hemp-derived cannabidiols aren’t typical products subject to FDA’s regulatory oversight, and the document stating its thinking on enforcement in the market submitted to the Office of Management and Budget isn’t a typical draft guidance.
No Enforcement Immunity For Testimonials On Immunity Or Claims With 'Alert: No COVID-19 Cure'
Elderberry syrup marketer Provezza Health targeted review of claims consumers may link to COVID-19 prevention or treatment due to testimonials not dispelled by the firm. FDA and FTC warn CBD firm to discontinue claims noting immunity-boosting is the “best defense” against COVID-19.
US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level
As it recently told Congress it would, FDA reopens docket on “Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived,. "Reopening the comment period will do nothing to protect public health when the FDA is already sitting on a ticking time bomb," says NPA head Daniel Fabricant.